. 2023 Sep 7;33(8):3735–3736. doi: 10.1007/s00590-023-03709-5

Table 3.

Intraoperative and postoperative outcomes

^Outcomes	^{Placebo Group}	^{TXA group}
^{Total blood loss (mL)}	^{807.30 ± 389.75}	^{618.91 ± 282.72}
^{Hidden blood loss (mL)}	^{619.47 ± 311.93}	^{438.86 ± 265.61}
^{Intraoperative blood loss (mL)}	^{136.09 ± 86.19}	^{103.60 ± 75.75}
^{Transfusion rate (n)}	^{456 (n = 1118)}	^{232 (n = 1112)}
^{Post-operative Hb level day 1 (g/L)}	^{95.55 ± 28.17}	^{104.42 ± 13.72}
^{Post-operative Hb level day 3 (g/L)}	^{84.30 ± 17.79}	^{91.46 ± 14.74}
^{Incidence of post-operative DVT (n)}	^{28 (n = 830)}	^{34 (n = 831)}
^{Incidence of post-operative PE (n)}	^{9 (n = 702)}	^{7 (n = 689)}
^{Length of hospital stay (Days)}	^{11.19 ± 5.80}	^{10.13 ± 4.11}
^{Operation time (Minutes)}	^{80.30 ± 32.07}	^{79.99 ± 30.96}

DVT deep vein thrombosis, Hb hemoglobin, PE pulmonary embolism